CNV1014802 hydrochloride is primarily investigated for its potential therapeutic applications in the field of neuroscience, particularly in the treatment of neurological disorders. It is being studied for its efficacy in managing epilepsy and neuropathic pain due to its ability to modulate specific ion channels in the nervous system. Additionally, this compound shows promise in addressing psychiatric conditions such as bipolar disorder and schizophrenia, as it may help stabilize mood and reduce symptoms associated with these disorders. Research is ongoing to explore its safety, pharmacokinetics, and potential as a targeted treatment for central nervous system-related ailments.